Pacira Pharmaceuticals (PCRX) PT Raised to $67 at Northland Capital Markets
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.12 -0.26%
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Northland Capital Markets analyst Tim Chiang raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $67.00 (from $61.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
- Pou Sheng International (Holdings) Limited (3813:HK) (PSHGF) PT Raised to HK$0.54 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
